Creative Medical Technology Holdings, Inc. - SEC Filing Summary

This SEC filing details a transaction where Creative Medical Technology Holdings, Inc. (CELZ) acquired 4,000,000 shares of BioDefense, Inc. stock from Creative Acquisition Corp. (CAC) for $200,000 cash and 1,000,000 shares of CELZ common stock. Following this transaction, CELZ owns 80% of BioDefense, and CAC owns 20%. Timothy Warbington, CEO of CAC, indirectly owns all of CAC's shares and beneficially owns the shares held by CAC. Post-transaction, Warbington beneficially owns 12,209 CELZ shares directly, 1,000,000 shares through CAC, and 22,695 shares through Creative Medical Health, Inc. (CMH), where he also holds a significant ownership stake and officer position. The filing also notes a grant of 1,000,000 shares of CELZ common stock to CAC, with a transaction price of $0.00, and an indirect ownership of 1,034,904 shares post-transaction.